IL164597A0 - Substituted 3-amino-thienoÄ2,3-bÜpyridine-2-carboxylic acid amide compounds and processes for preparing and their uses - Google Patents

Substituted 3-amino-thienoÄ2,3-bÜpyridine-2-carboxylic acid amide compounds and processes for preparing and their uses

Info

Publication number: IL164597A0
Authority: IL; Israel
Prior art keywords: thienoä2; büpyridine; amino; substituted; preparing
Prior art date: 2002-06-06

Application number

IL16459704A

Other languages

English (en)

Original Assignee

Boehringer Ingelheim Pharma

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2002-06-06

Filing date

2004-10-14

Publication date

2005-12-18

2004-10-14 Application filed by Boehringer Ingelheim Pharma filed Critical Boehringer Ingelheim Pharma

2005-12-18 Publication of IL164597A0 publication Critical patent/IL164597A0/xx

Links

150000001875 compounds Chemical class 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D495/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms
- C07D495/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having sulfur atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D495/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/04—Drugs for disorders of the muscular or neuromuscular system for myasthenia gravis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/02—Antidotes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/68—Polyesters containing atoms other than carbon, hydrogen and oxygen
- C08G63/695—Polyesters containing atoms other than carbon, hydrogen and oxygen containing silicon
- C08G63/6954—Polyesters containing atoms other than carbon, hydrogen and oxygen containing silicon derived from polxycarboxylic acids and polyhydroxy compounds
- C08G63/6956—Dicarboxylic acids and dihydroxy compounds
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08G—MACROMOLECULAR COMPOUNDS OBTAINED OTHERWISE THAN BY REACTIONS ONLY INVOLVING UNSATURATED CARBON-TO-CARBON BONDS
- C08G63/00—Macromolecular compounds obtained by reactions forming a carboxylic ester link in the main chain of the macromolecule
- C08G63/91—Polymers modified by chemical after-treatment
- C08G63/914—Polymers modified by chemical after-treatment derived from polycarboxylic acids and polyhydroxy compounds
- C08G63/916—Dicarboxylic acids and dihydroxy compounds

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Immunology (AREA)
Pulmonology (AREA)
Neurology (AREA)
Polymers & Plastics (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Biomedical Technology (AREA)
Diabetes (AREA)
Dermatology (AREA)
Urology & Nephrology (AREA)
Toxicology (AREA)
Orthopedic Medicine & Surgery (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Pain & Pain Management (AREA)
Physical Education & Sports Medicine (AREA)
Rheumatology (AREA)
Hematology (AREA)
Endocrinology (AREA)
Psychiatry (AREA)
Hospice & Palliative Care (AREA)
Vascular Medicine (AREA)
Obesity (AREA)
Emergency Medicine (AREA)
Oncology (AREA)

IL16459704A 2002-06-06 2004-10-14 Substituted 3-amino-thienoÄ2,3-bÜpyridine-2-carboxylic acid amide compounds and processes for preparing and their uses IL164597A0 (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US38631202P	2002-06-06	2002-06-06
US45786703P	2003-03-26	2003-03-26
PCT/US2003/017343 WO2003103661A1 (en)	2002-06-06	2003-06-03	SUBSTITUTED 3-AMINO-THIENO[2,3-b]PYRIDINE-2-CARBOXYLIC ACID AMIDE COMPOUNDS AND PROCESSES FOR PREPARING AND THEIR USES

Publications (1)

Publication Number	Publication Date
IL164597A0 true IL164597A0 (en)	2005-12-18

Family

ID=29739900

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IL16459704A IL164597A0 (en)	2002-06-06	2004-10-14	Substituted 3-amino-thienoÄ2,3-bÜpyridine-2-carboxylic acid amide compounds and processes for preparing and their uses

Country Status (26)

Country	Link
US (2)	US6964956B2 (sr)
EP (2)	EP2008654A1 (sr)
JP (2)	JP4364120B2 (sr)
KR (1)	KR20050005548A (sr)
CN (1)	CN100386329C (sr)
AR (1)	AR040250A1 (sr)
AT (1)	ATE415966T1 (sr)
AU (1)	AU2003237330A1 (sr)
BR (1)	BR0311605A (sr)
CA (1)	CA2483890C (sr)
DE (1)	DE60325051D1 (sr)
DK (1)	DK1513516T3 (sr)
EA (1)	EA008706B1 (sr)
ES (1)	ES2318141T3 (sr)
HR (1)	HRP20041154A2 (sr)
IL (1)	IL164597A0 (sr)
ME (2)	MEP53508A (sr)
MX (1)	MXPA04011246A (sr)
NO (1)	NO20044599L (sr)
NZ (1)	NZ537394A (sr)
PE (1)	PE20040539A1 (sr)
PL (1)	PL373424A1 (sr)
RS (1)	RS105204A (sr)
TW (1)	TWI296927B (sr)
UY (1)	UY27834A1 (sr)
WO (1)	WO2003103661A1 (sr)

Families Citing this family (51)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US7780785B2 (en)	2001-10-26	2010-08-24	Applied Materials, Inc.	Gas delivery apparatus for atomic layer deposition
DK1513516T3 (da)	2002-06-06	2009-10-19	Boehringer Ingelheim Pharma	Substitueret 3-amino-thieno(2,3-b)-pyridin-2-carboxylsyreamid-forbindelser og fremgangsmåder til fremstilling og deres anvendelser
GB0214268D0 (en) *	2002-06-20	2002-07-31	Celltech R&D Ltd	Chemical compounds
JP2006512313A (ja) *	2002-10-31	2006-04-13	アムジェンインコーポレイテッド	抗炎症剤
WO2005012283A1 (en) *	2003-07-31	2005-02-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted benzothiophene compounds and uses thereof
US7291733B2 (en) *	2003-10-10	2007-11-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted tricyclic heterocycles and their uses
US7119102B2 (en) *	2003-12-05	2006-10-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
AU2005233437A1 (en) *	2004-04-12	2005-10-27	Sankyo Company, Limited	Thienopyridine derivatives
KR100822681B1 (ko) *	2004-05-04	2008-04-17	에프. 호프만-라 로슈 아게	Ｉｋｋ 억제제로서의 티에노피리다진
KR100796965B1 (ko) *	2004-05-04	2008-01-22	에프. 호프만-라 로슈 아게	Ｉｋｋ 저해제로서의 티에노피리딘
EP1753428A4 (en) *	2004-05-14	2010-09-15	Abbott Lab	INHIBITORS OF KINASES AS THERAPEUTIC AGENTS
BRPI0510137A (pt) *	2004-05-19	2007-10-02	Solvay Pharm Gmbh	medicamentos contendo n-sulfamoil-n'-arilpiperazinas para a profilaxia ou tratamento da obesidade e condições relacionadas
US7598259B2 (en)	2004-06-15	2009-10-06	Schering Corporation	mGluR1 antagonists as therapeutic agents
JP2007277093A (ja) *	2004-06-21	2007-10-25	Astellas Pharma Inc	三環系化合物
AR050253A1 (es)	2004-06-24	2006-10-11	Smithkline Beecham Corp	Compuesto derivado de indazol carboxamida, composicion que lo comprende y su uso para la preparacion de un medicamento
TW200626142A (en)	2004-09-21	2006-08-01	Glaxo Group Ltd	Chemical compounds
JP5173429B2 (ja) *	2004-12-09	2013-04-03	ゼンション・リミテッド	化合物
EP1683799A1 (de) *	2005-01-12	2006-07-26	IBFB Pharma GmbH	3-Amino-6aryl(bzw.6-heteroaryl)-4-R²-thieno[2,3-b]pyridin-2-carbonsäureamide, diese enthaltende pharmazeutische Zubereitungen und deren Verwendung als Inhibitoren der TNFalpha-Freisetzung
WO2006074919A2 (de) *	2005-01-12	2006-07-20	Curacyte Discovery Gmbh	3 -AMINO- 6-ARYL (BZW.6-HETEROARYL) -THIENO [2 , 3-B] PYRIDIN-2-CARBONSÄUREAMIDE, DIESE ENTHALTENDE PHARMAZEUTISCHE ZUBEREITUNGEN UND IHRE VERWENDUNG ALS INHIBITOREN DER TNFα-FREISETZUNG
EP1681292A1 (de) *	2005-01-12	2006-07-19	IBFB Pharma GmbH	3-Amino-6-aryl(bzw.6-heteroaryl)-thieno¬2,3-b\|pyridin-2-carbonsäureamide, diese enthaltende pharmazeutische Zubereitungen und ihre Verwendung als Inhibitoren der TNFalpha-Freisetzung
US7465742B2 (en) *	2005-02-11	2008-12-16	Huanming Chen	Heterocyclic compounds having anti-HBV activity
EP1908480A4 (en) *	2005-06-03	2009-07-01	Riken	INTERFERON-ALPHA-REGULATOR
CN1884262B (zh) *	2005-06-24	2014-06-25	中国人民解放军军事医学科学院毒物药物研究所	4-氨基哌啶类化合物及其医药用途
NZ563687A (en)	2005-06-30	2011-07-29	Smithkline Beecham Corp	3-[1-(ethylsulfonyl)-4-piperidinyl]-5-[2-(1-methylethyl)-2,3-dihydro-1H-isoindol-5-yl]-1H-indole-7-carboxamide for inhibiting IKK2 (aka IKKbeta)
US8063071B2 (en)	2007-10-31	2011-11-22	GlaxoSmithKline, LLC	Chemical compounds
AR056200A1 (es) *	2005-09-27	2007-09-26	Wyeth Corp	Tieno [2,3-b]piridin-5-carbonitrilos como inhibidores de proteina quinasa
WO2007043581A1 (ja) *	2005-10-12	2007-04-19	Daiichi Sankyo Company, Limited	チエノピリジン－２－カルボキサミド誘導体
KR100846988B1 (ko) *	2006-03-06	2008-07-16	제일약품주식회사	신규한 티에노피리미딘 유도체 또는 이의 약학적으로허용가능한 염, 이의 제조방법 및 이를 함유하는 약학조성물
JP2009539865A (ja) *	2006-06-06	2009-11-19	ベーリンガーインゲルハイムインターナショナルゲゼルシャフトミットベシュレンクテルハフツング	置換３−アミノ−チエノ［２，３−ｂ］ピリジン２−カルボン酸アミド化合物及び製造方法及びそれらの使用
US20080032409A1 (en) *	2006-08-07	2008-02-07	California Institute Of Technology	Fluorescent biomolecule labeling reagents
WO2008020622A1 (en) *	2006-08-17	2008-02-21	Kyorin Pharmaceutical Co., Ltd.	NOVEL THIENO[2,3-d]PYRIMIDINE COMPOUND
PE20081889A1 (es)	2007-03-23	2009-03-05	Smithkline Beecham Corp	Indol carboxamidas como inhibidores de ikk2
CN101684123B (zh) *	2008-09-27	2013-12-11	四川大学	2-甲酰胺基噻吩并吡啶衍生物制备方法及医药用途
WO2010102968A1 (en)	2009-03-10	2010-09-16	Glaxo Group Limited	Indole derivatives as ikk2 inhibitors
US8481547B2 (en) *	2009-12-18	2013-07-09	Janssen Pharmaceutica Nv	Substituted benzothiazole and benzoxazole derivatives useful as inhibitors of DPP-1
US10531655B2 (en)	2011-12-02	2020-01-14	The Regents Of The University Of California	Reperfusion protection solution and uses thereof
HRP20161578T1 (hr) *	2012-02-09	2016-12-30	Merck Patent Gmbh	Derivati furo[3, 2-b]piridina kao inhibitori tbk1 i ikk
KR101468207B1 (ko) *	2013-02-14	2014-12-01	한국화학연구원	신규한 싸이에노[3,2-b]피리딜 우레아 유도체 또는 이의 약학적으로 허용가능한 염, 이의 제조방법 및 이를 유효성분으로 포함하는 유로텐신-Ⅱ 수용체 활성 관련 질환의 예방 또는 치료용 약학적 조성물
CN105829296A (zh)	2013-12-18	2016-08-03	巴斯夫欧洲公司	带有亚胺衍生的取代基的唑类化合物
RU2557550C1 (ru) *	2014-06-16	2015-07-27	Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Кубанский государственный аграрный университет"	Антидот гербицида 2,4-дихлорфеноксиуксусной кислоты на подсолнечнике
CA2988421A1 (en)	2015-06-01	2016-12-08	The Scripps Research Institute	Small molecule analogs of the nemo binding peptide
MX390651B (es) *	2015-11-03	2025-03-21	Apriligen Inc	Compuestos para el tratamiento de trastornos hipoproliferativos
TWI753910B (zh) *	2016-05-16	2022-02-01	美商拜歐斯瑞克斯公司	吡啶硫酮、其醫藥組合物及其治療增生性、炎性、神經退化性或免疫介導疾病之治療用途
US20210230179A1 (en) *	2018-06-06	2021-07-29	Institut National De La Sante Et De La Recherche Medicale (Inserm)	Thieno[2,3-b]pyridine derivatives as epac inhibitors and their pharmaceutical uses
US12281080B2 (en)	2018-08-21	2025-04-22	University Of South Carolina	Quinoline-based compounds and methods of inhibiting CDK8/19
US11014906B2 (en)	2018-08-21	2021-05-25	University Of South Carolina	Quinoline-based compounds and methods of inhibiting CDK8/19
CA3128377A1 (en) *	2019-02-01	2020-08-06	University Of South Carolina	Bicyclic pyridine compositions and methods of using the same for cancer therapy
US20220226343A1 (en) *	2019-05-21	2022-07-21	University Of South Carolina	3-amino-4-[4-[4 (dimethylcarbamoyl) phenyl]-1,4-diazepan-1-yl]thieno[2,3-b]pyridine-2-carboxamide for use in cancer therapy and formulations comprising the same
CN113248353B (zh) *	2021-07-01	2022-02-25	山东国邦药业有限公司	一种2,4-二氯-5-氟苯乙酮的制备方法
CN115725987B (zh) *	2021-08-31	2025-04-29	赤壁市高质量发展研究院有限公司	一种4-吡啶甲醇的制备方法
CN115716802A (zh) *	2022-10-20	2023-02-28	山西永津集团有限公司	一种4-溴-2-氯烟腈的合成方法

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS50140487A (sr) *	1974-04-15	1975-11-11
WO1992003427A1 (fr) *	1990-08-17	1992-03-05	Yoshitomi Pharmaceutical Industries, Ltd.	Compose de cetone et remede pour l'osteoporose
US5852046A (en)	1993-08-03	1998-12-22	Hoechst Aktiengesellschaft	Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
JP3254843B2 (ja) *	1993-08-09	2002-02-12	三菱ウェルファーマ株式会社	新規縮合ヘテロ環誘導体
US5350748A (en)	1993-08-18	1994-09-27	Warner-Lambert Company	3-thio or amino substituted-benzo[b]thiophene-2-carboxamides and 3-oxygen, thio, or amino substituted-benzofuran-2-carboxamides as inhibitors of cell adhesion
DE4420922A1 (de)	1994-06-16	1995-12-21	Bayer Ag	Verfahren zur Herstellung von Benzothiophenderivaten
US5656638A (en) *	1995-04-18	1997-08-12	Geron Corporation	Telomerase inhibitors
US6313301B1 (en)	1997-08-13	2001-11-06	Takeda Chemical Industries, Ltd.	Thienopyridine derivatives, their intermediates and production thereof
US6232320B1 (en) *	1998-06-04	2001-05-15	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
ATE266662T1 (de) *	1998-07-22	2004-05-15	Daiichi Suntory Pharma Co Ltd	Nf-kappa b inhibitoren, die indanderivate als aktiven bestandteil enthalten
TW564247B (en)	1999-04-08	2003-12-01	Akzo Nobel Nv	Bicyclic heteraromatic compound
WO2000075145A1 (en)	1999-06-03	2000-12-14	Abbott Laboratories	Cell adhesion-inhibiting antiinflammatory compounds
SI1194425T1 (sl)	1999-06-23	2005-12-31	Sanofi Aventis Deutschland	Substituirani benzimidazoli
DE19951360A1 (de)	1999-10-26	2001-05-03	Aventis Pharma Gmbh	Substituierte Indole
GB0003154D0 (en)	2000-02-12	2000-04-05	Astrazeneca Uk Ltd	Novel compounds
WO2001068648A1 (en)	2000-03-15	2001-09-20	Aventis Pharma Deutschland Gmbh	Substituted beta-carbolines with ikb-kinase inhibiting activity
CN1186324C (zh) *	2000-04-27	2005-01-26	山之内制药株式会社	稠合杂芳基衍生物
JP2003535867A (ja) *	2000-06-06	2003-12-02	ファイザープロダクツインコーポレイテッド	抗癌剤として有用なチオフェン誘導体
CA2427284A1 (en)	2000-10-26	2002-05-30	Tularik Inc.	Antiinflammation agents
MXPA04000563A (es)	2001-07-20	2004-07-08	Emerald Bioagriculture Corp	Canales de iones de planta y metodo.
AU2002356871A1 (en)	2001-10-30	2003-05-12	Pharmacia Corporation	Heteroaromatic carboxamide derivatives for the treatment of inflammation
US6974870B2 (en)	2002-06-06	2005-12-13	Boehringer Ingelheim Phamaceuticals, Inc.	Substituted 3-amino-thieno [2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
DK1513516T3 (da)	2002-06-06	2009-10-19	Boehringer Ingelheim Pharma	Substitueret 3-amino-thieno(2,3-b)-pyridin-2-carboxylsyreamid-forbindelser og fremgangsmåder til fremstilling og deres anvendelser
WO2005001849A1 (fr)	2003-06-27	2005-01-06	Eremeev, Petr Igorevich	Procede de prise en charge du combustible nucleaire epuise
WO2005012283A1 (en)	2003-07-31	2005-02-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted benzothiophene compounds and uses thereof
US7291733B2 (en)	2003-10-10	2007-11-06	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted tricyclic heterocycles and their uses
US7119102B2 (en)	2003-12-05	2006-10-10	Boehringer Ingelheim Pharmaceuticals, Inc.	Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
JP2005194198A (ja)	2003-12-26	2005-07-21	Takeda Chem Ind Ltd	チエノピリジン化合物
JP2008507518A (ja) *	2004-07-22	2008-03-13	ピーティーシーセラピューティクス，インコーポレーテッド	Ｃ型肝炎を治療するためのチエノピリジン
GB0420719D0 (en)	2004-09-17	2004-10-20	Addex Pharmaceuticals Sa	Novel allosteric modulators
MX2007004783A (es)	2004-10-21	2007-05-11	Pfizer	Inhibidores de la proteasa del virus de la hepatitis c, y composiciones y tratamientos que los usan.
US20060293709A1 (en)	2005-06-24	2006-12-28	Bojarski Raymond A	Tissue repair device

2003
- 2003-06-03 DK DK03736796T patent/DK1513516T3/da active
- 2003-06-03 EP EP08164478A patent/EP2008654A1/en not_active Withdrawn
- 2003-06-03 CA CA2483890A patent/CA2483890C/en not_active Expired - Fee Related
- 2003-06-03 JP JP2004510780A patent/JP4364120B2/ja not_active Expired - Fee Related
- 2003-06-03 AT AT03736796T patent/ATE415966T1/de active
- 2003-06-03 EP EP03736796A patent/EP1513516B1/en not_active Expired - Lifetime
- 2003-06-03 BR BR0311605-0A patent/BR0311605A/pt not_active IP Right Cessation
- 2003-06-03 DE DE60325051T patent/DE60325051D1/de not_active Expired - Lifetime
- 2003-06-03 AU AU2003237330A patent/AU2003237330A1/en not_active Abandoned
- 2003-06-03 WO PCT/US2003/017343 patent/WO2003103661A1/en not_active Ceased
- 2003-06-03 CN CNB038099586A patent/CN100386329C/zh not_active Expired - Fee Related
- 2003-06-03 RS YU105204A patent/RS105204A/sr unknown
- 2003-06-03 ME MEP-535/08A patent/MEP53508A/xx unknown
- 2003-06-03 MX MXPA04011246A patent/MXPA04011246A/es not_active Application Discontinuation
- 2003-06-03 EA EA200401541A patent/EA008706B1/ru not_active IP Right Cessation
- 2003-06-03 KR KR10-2004-7019850A patent/KR20050005548A/ko not_active Ceased
- 2003-06-03 PL PL03373424A patent/PL373424A1/xx not_active Application Discontinuation
- 2003-06-03 UY UY27834A patent/UY27834A1/es not_active Application Discontinuation
- 2003-06-03 ES ES03736796T patent/ES2318141T3/es not_active Expired - Lifetime
- 2003-06-03 ME MEP-2008-535A patent/ME00355B/me unknown
- 2003-06-03 NZ NZ537394A patent/NZ537394A/en unknown
- 2003-06-03 US US10/453,175 patent/US6964956B2/en not_active Expired - Lifetime
- 2003-06-03 HR HR20041154A patent/HRP20041154A2/hr not_active Application Discontinuation
- 2003-06-04 PE PE2003000560A patent/PE20040539A1/es not_active Application Discontinuation
- 2003-06-05 TW TW092115243A patent/TWI296927B/zh active
- 2003-06-06 AR ARP030102022A patent/AR040250A1/es unknown
2004
- 2004-10-14 IL IL16459704A patent/IL164597A0/xx unknown
- 2004-10-25 NO NO20044599A patent/NO20044599L/no not_active Application Discontinuation
2005
- 2005-08-18 US US11/206,707 patent/US7405225B2/en not_active Expired - Lifetime
2009
- 2009-02-18 JP JP2009035787A patent/JP2009102447A/ja active Pending

Also Published As

Publication number	Publication date
US7405225B2 (en)	2008-07-29
DE60325051D1 (de)	2009-01-15
EA200401541A1 (ru)	2005-06-30
JP2005530816A (ja)	2005-10-13
US6964956B2 (en)	2005-11-15
NZ537394A (en)	2006-12-22
DK1513516T3 (da)	2009-10-19
EP1513516A1 (en)	2005-03-16
NO20044599L (no)	2005-02-16
TWI296927B (en)	2008-05-21
PL373424A1 (en)	2005-08-22
KR20050005548A (ko)	2005-01-13
BR0311605A (pt)	2005-02-22
US20050288285A1 (en)	2005-12-29
AR040250A1 (es)	2005-03-23
TW200401640A (en)	2004-02-01
CN1649581A (zh)	2005-08-03
AU2003237330A1 (en)	2003-12-22
CA2483890C (en)	2012-12-11
EP1513516B1 (en)	2008-12-03
ATE415966T1 (de)	2008-12-15
ES2318141T3 (es)	2009-05-01
UY27834A1 (es)	2003-12-31
EP2008654A1 (en)	2008-12-31
JP4364120B2 (ja)	2009-11-11
EA008706B1 (ru)	2007-06-29
PE20040539A1 (es)	2004-10-21
CA2483890A1 (en)	2003-12-18
HK1080737A1 (zh)	2006-05-04
MEP53508A (en)	2011-05-10
CN100386329C (zh)	2008-05-07
JP2009102447A (ja)	2009-05-14
US20040053957A1 (en)	2004-03-18
ME00355B (me)	2010-06-30
WO2003103661A1 (en)	2003-12-18
MXPA04011246A (es)	2005-06-03
RS105204A (sr)	2006-12-15
HRP20041154A2 (en)	2005-06-30

Publication	Publication Date	Title
IL164597A0 (en)	2005-12-18	Substituted 3-amino-thienoÄ2,3-bÜpyridine-2-carboxylic acid amide compounds and processes for preparing and their uses
GB0213599D0 (en)	2002-07-24	Process
PL377187A1 (pl)	2006-01-23	Związki ze skondensowanym pierścieniem 1,3-dihydroimidazolowym
GB0210143D0 (en)	2002-06-12	Process
HRP20050328A2 (en)	2005-06-30	Process for the preparation of (s,s)-cis-2-benzhyd
PL376399A1 (en)	2005-12-27	Pyridopyrimidinone compounds, method for production thereof and medicaments comprising the same
GB0213485D0 (en)	2002-07-24	Process
GB0205016D0 (en)	2002-04-17	Process
PL370740A1 (en)	2005-05-30	Pyridyloxyalkanoic acid amide derivatives useful as fungicides
GB0201505D0 (en)	2002-03-13	Process
GB0210225D0 (en)	2002-06-12	Process
GB0205014D0 (en)	2002-04-17	Process
GB0202564D0 (en)	2002-03-20	Process
EG23973A (en)	2008-02-24	Process for the preparation of urea ganules
IL173884A0 (en)	2006-07-05	Cycloalkylaminoacid compounds, processes for making and uses thereof
IL173654A0 (en)	2006-07-05	1-carbamoylcycloalkylcarboxylic acid compounds, processes for making and uses thereof
GB0202563D0 (en)	2002-03-20	Process
GB0212974D0 (en)	2002-07-17	Process
IL164407A0 (en)	2005-12-18	Processes for preparing heteroaryl and unsaturatedheterocycloalkylmagnesium compounds
GB0210183D0 (en)	2002-06-12	Process
IL173447A0 (en)	2006-06-11	Substituted benzoylureido-o-benzoylamides, method for the production thereof and use of the same
PL374000A1 (en)	2005-09-19	Improved process for hydroxyazapirones
IL164437A0 (en)	2005-12-18	Method for the production of 2,4,5-trimethylphenylacetic acid
GB0203665D0 (en)	2002-04-03	Process
AU2003284212A8 (en)	2004-05-13	Process for the preparation of (s,s)-cis-2-phenyl-3-aminopiperidine